Topic Highlight
Copyright ©The Author(s) 2016.
World J Gastroenterol. Jul 14, 2016; 22(26): 5950-5957
Published online Jul 14, 2016. doi: 10.3748/wjg.v22.i26.5950
Table 1 Characteristics of randomized trials evaluating selective intestinal decontamination in liver transplant
Ref.Type of studySID regimenTreatment perioperative (48 h)Patients (n)
Patients with infection, n (%)
Period of observation posttransplantation (d)
SIDControlSIDControl
Bion et al[50], 1994Randomized trial not placebo controlledTobramycin, amphotericin and polymyxin B for 5-15 d posttransplantationCefotaxime and ampicillin21313 (14.3)12 (38.7)15 d or until hospital discharge
Arnow et al[51], 1996Randomized trial not placebo controlledGentamicin, polymyxin and nystatin orally for 21 d posttransplantationCefotaxime and ampicillin363314 (38.9)14 (42.4)28
Hellinger et al[53], 2002Randomized placebo-controlled trialGentamicin, polymyxin E and nystatin 4 x/d for 21 d posttransplantationCeftizoxime374312 (32.4)12 (28.9)60
Zwaveling et al[28], 2002Randomized placebo-controlled trialNorfloxacin, colitin,tobramycin and amphotericin BCefotaxime and tobramycin292922 (75.9)25 (86.2)30
Table 2 Characteristics of observational studies evaluating selective intestinal decontamination in liver transplant
Ref.Type of studySID regimenOther antibioticsPatients (n)
Patients with infection, n (%)
Period of observation posttransplantation (d)
SIDControlSIDControl
Gorensek et al[47], 1993Prospective nonrandomized study with historical controlNorfloxacin and nistatin. Oropharyngeal paste (polymyxin, gentamicin, nystatin)Metronidazole and Third-generation cephalosporins for 5 d17341 (5.9)118 (52.9)130
San-Juan et al[54], 2011Prospective cohort studyFluoroquinolones (norfloxacin or ciprofloxacin) 7 dFirst- or second- or third generation cephalosporins, or antipseudomonal beta-lactams or glycopeptides415595110 (26.5)156 (26.21)30
Sun et al[49], 2012Retrospective uncontrolled studyRifaximinCefotaxime and ampicillin for 24 h30807 (23.3)23 (28.7)90
Katchman et al[55], 2014Retrospective cohort studyColitin, gentamicin and nystatinCefazolin and metronidazole for 4 d1113747 (42.7)18 (46.8)30